AIMS: Adrenomedullin is a newly described peptide that has widespread tissue distribution. Its presence in cardiovascular (including vascular endothelial cells, smooth muscle cells, and cardiac atria and ventricles) and renal tissues, together with its vasodilatory and natriuretic properties, suggest a role in blood pressure regulation and fluid and electrolyte balance. METHODS: Nine normal volunteers were studied to determine whether or not adrenomedullin influenced plasma atrial natriuretic peptide and arginine vasopressin concentrations during systemic angiotensin II infusion. RESULTS: A significant (P = 0.02) augmentation of atrial natriuretic peptide concentrations, but no suppression of arginine vasopressin concentrations, was found with coinfusion of adrenomedullin and angiotensin II when compared with vehicle and angiotensin II. CONCLUSIONS: Despite its vasodilator and natriuretic action, adrenomedullin significantly augmented angiotensin II-stimulated plasma atrial natriuretic peptide concentrations in healthy humans. This provides further evidence of a synergistic interaction between adrenomedullin and atrial natriuretic peptide and suggests that adrenomedullin may have a role in fluid and electrolyte balance and blood pressure regulation.
AIMS: Adrenomedullin is a newly described peptide that has widespread tissue distribution. Its presence in cardiovascular (including vascular endothelial cells, smooth muscle cells, and cardiac atria and ventricles) and renal tissues, together with its vasodilatory and natriuretic properties, suggest a role in blood pressure regulation and fluid and electrolyte balance. METHODS: Nine normal volunteers were studied to determine whether or not adrenomedullin influenced plasma atrial natriuretic peptide and arginine vasopressin concentrations during systemic angiotensin II infusion. RESULTS: A significant (P = 0.02) augmentation of atrial natriuretic peptide concentrations, but no suppression of arginine vasopressin concentrations, was found with coinfusion of adrenomedullin and angiotensin II when compared with vehicle and angiotensin II. CONCLUSIONS: Despite its vasodilator and natriuretic action, adrenomedullin significantly augmented angiotensin II-stimulated plasma atrial natriuretic peptide concentrations in healthy humans. This provides further evidence of a synergistic interaction between adrenomedullin and atrial natriuretic peptide and suggests that adrenomedullin may have a role in fluid and electrolyte balance and blood pressure regulation.
Authors: M T Rademaker; C J Charles; L K Lewis; T G Yandle; G J Cooper; D H Coy; A M Richards; M G Nicholls Journal: Circulation Date: 1997-09-16 Impact factor: 29.690
Authors: T Nishikimi; Y Saito; K Kitamura; T Ishimitsu; T Eto; K Kangawa; H Matsuo; T Omae; H Matsuoka Journal: J Am Coll Cardiol Date: 1995-11-15 Impact factor: 24.094
Authors: Kieran F Docherty; Ross T Campbell; Katriona J M Brooksbank; John G Dreisbach; Paul Forsyth; Rosemary L Godeseth; Tracey Hopkins; Alice M Jackson; Matthew M Y Lee; Alex McConnachie; Giles Roditi; Iain B Squire; Bethany Stanley; Paul Welsh; Pardeep S Jhund; Mark C Petrie; John J V McMurray Journal: Circulation Date: 2021-05-13 Impact factor: 29.690
Authors: Henrike Arfsten; Georg Goliasch; Philipp E Bartko; Suriya Prausmüller; Georg Spinka; Anna Cho; Johannes Novak; Helmuth Haslacher; Guido Strunk; Joachim Struck; Martin Hülsmann; Noemi Pavo Journal: Br J Clin Pharmacol Date: 2020-07-20 Impact factor: 3.716